生物大分子药物传送系统及功能高效化的研究进展
被引量：2
摘要
综述了国内外现阶段生物大分子药物传送系统及功能高效化的进展。
出处
《华西药学杂志》
CAS
CSCD
北大核心
2008年第3期363-364,共2页
West China Journal of Pharmaceutical Sciences
参考文献10
-
1李婧.浅谈研究开发医药制剂的重要性[J].中国药事,2000,14(5):302-303. 被引量：2
-
2徐铮奎.畅销世界的十大医药制剂及今后几年新药开发动向[J].中国制药信息,2003,19(12):33-34. 被引量：1
-
3[3]Langer R,Lund D,Leong K,et al.Controlled release of macromol-ecules:Biological studies[J].J Control Releas,1985,2:331-341.
-
4杜光,刘东.单克隆抗体治疗肿瘤的研究概况[J].中国药师,2007,10(6):547-549. 被引量：1
-
5[5]YR Duan,WS Liu,ZB Zhang,et al.A study on PELGE nanoparti-cles as controlleddrug delivery systems for intravenous[J].Key Eng Mater,2005,288,163-166.
-
6[6]Xun Sun,You-Rong Duan,Zhi-Rong Zhang,et al.PELGE nanoparticles as new Carriers for the delivery of plasmid DNA[J].Chem Pharm Bull,2005,53(6):599-603.
-
7[7]Hai-Tao SHI,Tao GONG,Zhi-Rong Zhang,et al.Adsorption and desorption of insulin on Porous Hydroxyapatite Mierospheres[J].J Ceramic Soci Japan,2005,1321 (9):579-583.
-
8[8]Yang VC,Park YJ,Song H,et al.Application of the ATTEMPTS for delivery of macromolecular drugs[J].J Controll Release,2004,101:35-45.
-
9[9]Yang VC,Park YJ,Naik S,et al.ATTEMPTS:A heparin/prota-mine-based triggered release system for the delivery of enzyme drugs without associated side effects[J].Adv Drug Delivery Bey,2003,55:251-265.
-
10[10]Yang VC,Park YJ.Bieconjugates for effective drug targeting[J].Adv Drug Delivery Reviews,2003,55:169-170.
二级参考文献21
-
1汤仲明.生物技术药物的最新进展和展望.国外医药,2002,21(2):115-117.
-
2Green L.Antibody engineering via genetic eugineeritrg of the mouse:Xeuomouae strains are a vehicle for the facile generation of therapeutic human monoclonal antibodies[J].J.Immunol.Methods,1999,231(1～2):11-23
-
3Davis CG.Jia XC,Feng X,et al.Production of humanantibodies from transgenic mice[J].Methods Mol.Boil.,2004,248:191-200
-
4Borjesson PK.Postema EJ,Roos JC,et al.Radioimmunodetection and radioimmunothempy of head and neck cancer.[J].Oral Oncol,2004,40(8):761-772
-
5Wahl R L.The clinical importance of dosimetry in radioimmunotherapy with tositumomab and iodine I131 tositumomab[J].Semin Oncol,2003,30(4):31-38
-
6Readron DA,Quinn JA,Akabani G,et al.Novel human IgG2b/murine chimeric antitenascin monoclonal antibody construct radiolabeled with 131I and administered into the surgicany created resection cavity of patients with malignant glioma:phase I trial results[J].J Nncl Med.,2006,47(6):912-918
-
7Yang XD,Corvalan JR,Wang P,et al.Fully human anti-interleukin-8 monoclonal antibodies:Potential the repeutics for the treatment of in flammatory disease states[J].J.Leukoe Biol,1999,66(3):401-410
-
8Leyland JB.Targeting HER2:Hopes and realities[J].Lancet Oncol.,2002,3:137-141
-
9Armstrong D.K.Relapsed ovarian cancer:challenges for management strategies for a chronic disease[J].Oncologist,2002,7(Supple 5):20-28
-
10Pastan I.Hassan R.Fitzgerald DJ,et al.Immunotoxin therapy of cancer[J].Nat.Rev.Cancer,2006,6(7):559-565
同被引文献10
-
1Discher B.M., Won Y.Y., Ege D.S., et al. Polymersomes: Tough vesicles made from diblock copolymers [J]. Science, 1999, 284 (5417): 1143-1146.
-
2Cho M.J.,Juliano R. Macromolecular versus smallmolecule therapeutics: drug discovery, development and clinical considerations [J]. Trends Biotechnol, 1996, 14 (5): 153-158.
-
3Lasic D.D.,Papahadjopoulos D., Medical application of liposomes[M]. New York. 1998.
-
4Wu F.,Jin T. Polymer-based sustained-release dosage forms for protein drugs, challenges, and recent advances [J]. AAPS PhannSciTech, 2008, 9 (4): 1218-1229.
-
5Yuan W., Wu F., Guo M., et al. Development of protein delivery microsphere system by a novel S/O/O/W multi-emulsion [J]. Eur J Pharm Sci, 2009, 36 (2-3): 212-218.
-
6Battaglia G., Ryan A.J., Tomas S. Polymeric Vesicle Permeability: A Facile Chemical Assay [J]. Langmuir, 2006, 22 (11): 4910-4913.
-
7郑永霞,焦炳华.miRNA的生物形成及调控基因表达机制[J].生命的化学,2010,30(6):821-826. 被引量：13
-
8高丽,刘艾林,杜冠华.计算机辅助药物设计在新药研发中的应用进展[J].中国药学杂志,2011,46(9):641-645. 被引量：18
-
9SONG XiaoWei,SHAN DongKai,CHEN Jian,JING Qing.miRNAs and lncRNAs in vascular injury and remodeling[J].Science China(Life Sciences),2014,57(8):826-835. 被引量：17
-
10廖江铨,刘咏梅,王阶.miRNA在冠心病诊断和治疗中的研究进展[J].中国科学：生命科学,2015,45(8):748-754. 被引量：7
引证文献2
-
1张玉龙,袁伟恩,苏靖,吴飞,杜子秀.包封不对称膜高分子囊泡对PLGA微球中蛋白释放行为的改善作用[J].现代生物医学进展,2010,10(16):3123-3125.
-
2黄益,王江煌,于暕辰,高晓霞,袁洁.microRNA化学小分子抑制剂的研究进展[J].中国科学：生命科学,2016,46(12):1354-1369.
-
1郭仁宏,王金万.紫杉醇脂质体的研究进展[J].中国肿瘤,2008,17(8):698-703. 被引量：34
-
2张志荣,董尔丹,吴镭,张强,陆伟跃,姜威,孟庆峰,孙逊,何勤,李曼.生物大分子药物递送系统研究现状与前沿方向[J].中国基础科学,2014,16(5):3-8. 被引量：5
-
3王苹.医药物流的运作现状与存在问题及对策[J].中国医药导报,2014,11(23):132-135. 被引量：6
-
4刘刚.在药品监管工作中引入ISO9001质量管理体系的探讨[J].中国药事,2009,23(2):109-110. 被引量：2
-
5甄永苏.抗肿瘤单克隆抗体导向药物的研究进展[J].世界科技研究与发展,1999,21(5):5-7. 被引量：1
-
6何秋红.医药物流信息系统概述[J].海峡药学,2016,28(2):274-276.
-
7张永萍,魏斯超.浅谈计算机应用在教学中的应用[J].信息与电脑,2016,28(1):212-212.
-
8哈鹰,郑继旺.微机在神经药理实验室科研管理工作中的应用[J].中国药物滥用防治杂志,1996,2(2):16-18.
-
9医药[J].中国医院院长,2009(15):86-86.
-
10王萌.国内药品检验行业信息化的现状与展望[J].华夏医药,2006,1(1):66-67.
